nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—CYP3A4—Rosuvastatin—atherosclerosis	0.104	0.211	CbGbCtD
Flunisolide—CYP3A4—Ezetimibe—atherosclerosis	0.104	0.211	CbGbCtD
Flunisolide—CYP3A4—Simvastatin—atherosclerosis	0.0969	0.196	CbGbCtD
Flunisolide—CYP3A4—Pravastatin—atherosclerosis	0.0948	0.192	CbGbCtD
Flunisolide—CYP3A4—Lovastatin—atherosclerosis	0.0948	0.192	CbGbCtD
Flunisolide—Neck pain—Ezetimibe—atherosclerosis	0.00436	0.00948	CcSEcCtD
Flunisolide—Cataract—Simvastatin—atherosclerosis	0.00432	0.00938	CcSEcCtD
Flunisolide—Sensory loss—Pravastatin—atherosclerosis	0.00429	0.00932	CcSEcCtD
Flunisolide—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00425	0.00923	CcSEcCtD
Flunisolide—Cough increased—Niacin—atherosclerosis	0.00412	0.00896	CcSEcCtD
Flunisolide—Injury—Rosuvastatin—atherosclerosis	0.00409	0.0089	CcSEcCtD
Flunisolide—Cataract—Pravastatin—atherosclerosis	0.0039	0.00848	CcSEcCtD
Flunisolide—Vaginal inflammation—Niacin—atherosclerosis	0.00377	0.0082	CcSEcCtD
Flunisolide—Vaginal infection—Niacin—atherosclerosis	0.00356	0.00774	CcSEcCtD
Flunisolide—Injury—Lovastatin—atherosclerosis	0.00347	0.00754	CcSEcCtD
Flunisolide—Eczema—Simvastatin—atherosclerosis	0.00332	0.00721	CcSEcCtD
Flunisolide—Betamethasone—PLA2G1B—atherosclerosis	0.00325	0.43	CrCbGaD
Flunisolide—Bronchitis—Rosuvastatin—atherosclerosis	0.00313	0.0068	CcSEcCtD
Flunisolide—Eczema—Niacin—atherosclerosis	0.00305	0.00662	CcSEcCtD
Flunisolide—Injury—Pravastatin—atherosclerosis	0.00293	0.00638	CcSEcCtD
Flunisolide—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00282	0.00613	CcSEcCtD
Flunisolide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0028	0.00608	CcSEcCtD
Flunisolide—Sinusitis—Rosuvastatin—atherosclerosis	0.00272	0.00591	CcSEcCtD
Flunisolide—Migraine—Niacin—atherosclerosis	0.0027	0.00586	CcSEcCtD
Flunisolide—Abdominal discomfort—Lovastatin—atherosclerosis	0.00264	0.00574	CcSEcCtD
Flunisolide—Rhinitis—Rosuvastatin—atherosclerosis	0.00261	0.00567	CcSEcCtD
Flunisolide—Pharyngitis—Rosuvastatin—atherosclerosis	0.00258	0.00561	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00251	0.00546	CcSEcCtD
Flunisolide—Bronchitis—Simvastatin—atherosclerosis	0.00248	0.00539	CcSEcCtD
Flunisolide—Abdominal discomfort—Simvastatin—atherosclerosis	0.00247	0.00537	CcSEcCtD
Flunisolide—Nasopharyngitis—Pravastatin—atherosclerosis	0.00241	0.00524	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.0024	0.00521	CcSEcCtD
Flunisolide—Urinary tract infection—Lovastatin—atherosclerosis	0.00239	0.00519	CcSEcCtD
Flunisolide—CYP3A4—Irinotecan Pathway—NPC1—atherosclerosis	0.00239	0.0638	CbGpPWpGaD
Flunisolide—Abdominal distension—Niacin—atherosclerosis	0.00238	0.00518	CcSEcCtD
Flunisolide—Abdominal distension—Pravastatin—atherosclerosis	0.00235	0.0051	CcSEcCtD
Flunisolide—Sinusitis—Lovastatin—atherosclerosis	0.00231	0.00501	CcSEcCtD
Flunisolide—Bronchitis—Niacin—atherosclerosis	0.00228	0.00495	CcSEcCtD
Flunisolide—Sinusitis—Ezetimibe—atherosclerosis	0.00226	0.00491	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00217	0.00471	CcSEcCtD
Flunisolide—Sinusitis—Simvastatin—atherosclerosis	0.00216	0.00469	CcSEcCtD
Flunisolide—Pharyngitis—Ezetimibe—atherosclerosis	0.00215	0.00467	CcSEcCtD
Flunisolide—Oedema peripheral—Ezetimibe—atherosclerosis	0.00213	0.00463	CcSEcCtD
Flunisolide—Weight increased—Pravastatin—atherosclerosis	0.00212	0.00461	CcSEcCtD
Flunisolide—Erythema multiforme—Lovastatin—atherosclerosis	0.00209	0.00453	CcSEcCtD
Flunisolide—Stomatitis—Niacin—atherosclerosis	0.00206	0.00447	CcSEcCtD
Flunisolide—Erythema multiforme—Ezetimibe—atherosclerosis	0.00205	0.00445	CcSEcCtD
Flunisolide—Sweating—Niacin—atherosclerosis	0.00202	0.0044	CcSEcCtD
Flunisolide—Urinary tract infection—Pravastatin—atherosclerosis	0.00202	0.00439	CcSEcCtD
Flunisolide—Chills—Lovastatin—atherosclerosis	0.00198	0.0043	CcSEcCtD
Flunisolide—Cough—Rosuvastatin—atherosclerosis	0.00198	0.0043	CcSEcCtD
Flunisolide—Erythema multiforme—Simvastatin—atherosclerosis	0.00195	0.00424	CcSEcCtD
Flunisolide—Sinusitis—Pravastatin—atherosclerosis	0.00195	0.00424	CcSEcCtD
Flunisolide—Myalgia—Rosuvastatin—atherosclerosis	0.00193	0.00419	CcSEcCtD
Flunisolide—Rhinitis—Niacin—atherosclerosis	0.0019	0.00413	CcSEcCtD
Flunisolide—Dexamethasone—PLA2G1B—atherosclerosis	0.00189	0.25	CrCbGaD
Flunisolide—Hypoaesthesia—Niacin—atherosclerosis	0.00189	0.0041	CcSEcCtD
Flunisolide—Malnutrition—Ezetimibe—atherosclerosis	0.00188	0.00409	CcSEcCtD
Flunisolide—Dysgeusia—Lovastatin—atherosclerosis	0.00188	0.00409	CcSEcCtD
Flunisolide—Rhinitis—Pravastatin—atherosclerosis	0.00187	0.00406	CcSEcCtD
Flunisolide—Oedema peripheral—Niacin—atherosclerosis	0.00187	0.00406	CcSEcCtD
Flunisolide—Back pain—Lovastatin—atherosclerosis	0.00186	0.00404	CcSEcCtD
Flunisolide—Hypoaesthesia—Pravastatin—atherosclerosis	0.00186	0.00403	CcSEcCtD
Flunisolide—Pharyngitis—Pravastatin—atherosclerosis	0.00185	0.00402	CcSEcCtD
Flunisolide—Chills—Simvastatin—atherosclerosis	0.00185	0.00402	CcSEcCtD
Flunisolide—Infection—Rosuvastatin—atherosclerosis	0.00184	0.00399	CcSEcCtD
Flunisolide—Back pain—Ezetimibe—atherosclerosis	0.00182	0.00396	CcSEcCtD
Flunisolide—Vision blurred—Lovastatin—atherosclerosis	0.00181	0.00393	CcSEcCtD
Flunisolide—Tremor—Lovastatin—atherosclerosis	0.0018	0.00391	CcSEcCtD
Flunisolide—Ill-defined disorder—Lovastatin—atherosclerosis	0.00178	0.00387	CcSEcCtD
Flunisolide—Erythema multiforme—Pravastatin—atherosclerosis	0.00176	0.00383	CcSEcCtD
Flunisolide—Dysgeusia—Simvastatin—atherosclerosis	0.00176	0.00382	CcSEcCtD
Flunisolide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00175	0.0038	CcSEcCtD
Flunisolide—Malaise—Lovastatin—atherosclerosis	0.00173	0.00376	CcSEcCtD
Flunisolide—Vertigo—Lovastatin—atherosclerosis	0.00173	0.00375	CcSEcCtD
Flunisolide—Chills—Niacin—atherosclerosis	0.0017	0.00369	CcSEcCtD
Flunisolide—Malaise—Ezetimibe—atherosclerosis	0.0017	0.00369	CcSEcCtD
Flunisolide—Vision blurred—Simvastatin—atherosclerosis	0.00169	0.00368	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00168	0.00366	CcSEcCtD
Flunisolide—Tremor—Simvastatin—atherosclerosis	0.00168	0.00366	CcSEcCtD
Flunisolide—Chills—Pravastatin—atherosclerosis	0.00167	0.00364	CcSEcCtD
Flunisolide—Insomnia—Rosuvastatin—atherosclerosis	0.00167	0.00364	CcSEcCtD
Flunisolide—Ill-defined disorder—Simvastatin—atherosclerosis	0.00167	0.00362	CcSEcCtD
Flunisolide—Palpitations—Ezetimibe—atherosclerosis	0.00166	0.00362	CcSEcCtD
Flunisolide—Malnutrition—Niacin—atherosclerosis	0.00165	0.00358	CcSEcCtD
Flunisolide—Cough—Ezetimibe—atherosclerosis	0.00164	0.00357	CcSEcCtD
Flunisolide—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.00164	0.0439	CbGpPWpGaD
Flunisolide—Chest pain—Lovastatin—atherosclerosis	0.00163	0.00355	CcSEcCtD
Flunisolide—Myalgia—Lovastatin—atherosclerosis	0.00163	0.00355	CcSEcCtD
Flunisolide—Anxiety—Lovastatin—atherosclerosis	0.00163	0.00354	CcSEcCtD
Flunisolide—Dyspepsia—Rosuvastatin—atherosclerosis	0.00163	0.00354	CcSEcCtD
Flunisolide—Hypertension—Ezetimibe—atherosclerosis	0.00163	0.00353	CcSEcCtD
Flunisolide—Malaise—Simvastatin—atherosclerosis	0.00162	0.00352	CcSEcCtD
Flunisolide—Discomfort—Lovastatin—atherosclerosis	0.00162	0.00351	CcSEcCtD
Flunisolide—Vertigo—Simvastatin—atherosclerosis	0.00161	0.00351	CcSEcCtD
Flunisolide—Myalgia—Ezetimibe—atherosclerosis	0.0016	0.00348	CcSEcCtD
Flunisolide—Chest pain—Ezetimibe—atherosclerosis	0.0016	0.00348	CcSEcCtD
Flunisolide—Dysgeusia—Pravastatin—atherosclerosis	0.00159	0.00346	CcSEcCtD
Flunisolide—Discomfort—Ezetimibe—atherosclerosis	0.00158	0.00344	CcSEcCtD
Flunisolide—Pain—Rosuvastatin—atherosclerosis	0.00158	0.00344	CcSEcCtD
Flunisolide—Constipation—Rosuvastatin—atherosclerosis	0.00158	0.00344	CcSEcCtD
Flunisolide—Infection—Lovastatin—atherosclerosis	0.00156	0.00338	CcSEcCtD
Flunisolide—Vision blurred—Niacin—atherosclerosis	0.00155	0.00338	CcSEcCtD
Flunisolide—Vision blurred—Pravastatin—atherosclerosis	0.00153	0.00333	CcSEcCtD
Flunisolide—Chest pain—Simvastatin—atherosclerosis	0.00153	0.00332	CcSEcCtD
Flunisolide—Myalgia—Simvastatin—atherosclerosis	0.00153	0.00332	CcSEcCtD
Flunisolide—Infection—Ezetimibe—atherosclerosis	0.00153	0.00332	CcSEcCtD
Flunisolide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00152	0.00331	CcSEcCtD
Flunisolide—Anxiety—Simvastatin—atherosclerosis	0.00152	0.00331	CcSEcCtD
Flunisolide—Tremor—Pravastatin—atherosclerosis	0.00152	0.00331	CcSEcCtD
Flunisolide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00151	0.00329	CcSEcCtD
Flunisolide—Discomfort—Simvastatin—atherosclerosis	0.00151	0.00328	CcSEcCtD
Flunisolide—Ill-defined disorder—Pravastatin—atherosclerosis	0.00151	0.00327	CcSEcCtD
Flunisolide—Vertigo—Niacin—atherosclerosis	0.00148	0.00322	CcSEcCtD
Flunisolide—Syncope—Niacin—atherosclerosis	0.00148	0.00321	CcSEcCtD
Flunisolide—Urticaria—Rosuvastatin—atherosclerosis	0.00147	0.00319	CcSEcCtD
Flunisolide—Oedema—Simvastatin—atherosclerosis	0.00147	0.00319	CcSEcCtD
Flunisolide—Malaise—Pravastatin—atherosclerosis	0.00146	0.00318	CcSEcCtD
Flunisolide—Abdominal pain—Rosuvastatin—atherosclerosis	0.00146	0.00318	CcSEcCtD
Flunisolide—Vertigo—Pravastatin—atherosclerosis	0.00146	0.00317	CcSEcCtD
Flunisolide—Palpitations—Niacin—atherosclerosis	0.00146	0.00317	CcSEcCtD
Flunisolide—Infection—Simvastatin—atherosclerosis	0.00146	0.00317	CcSEcCtD
Flunisolide—Loss of consciousness—Niacin—atherosclerosis	0.00145	0.00315	CcSEcCtD
Flunisolide—Cough—Niacin—atherosclerosis	0.00144	0.00313	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00143	0.0031	CcSEcCtD
Flunisolide—Insomnia—Lovastatin—atherosclerosis	0.00142	0.00308	CcSEcCtD
Flunisolide—Cough—Pravastatin—atherosclerosis	0.00142	0.00308	CcSEcCtD
Flunisolide—Myalgia—Niacin—atherosclerosis	0.0014	0.00305	CcSEcCtD
Flunisolide—Hypertension—Pravastatin—atherosclerosis	0.0014	0.00305	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0014	0.00304	CcSEcCtD
Flunisolide—Dyspnoea—Lovastatin—atherosclerosis	0.0014	0.00304	CcSEcCtD
Flunisolide—Insomnia—Ezetimibe—atherosclerosis	0.00139	0.00302	CcSEcCtD
Flunisolide—Chest pain—Pravastatin—atherosclerosis	0.00138	0.003	CcSEcCtD
Flunisolide—Myalgia—Pravastatin—atherosclerosis	0.00138	0.003	CcSEcCtD
Flunisolide—Dyspepsia—Lovastatin—atherosclerosis	0.00138	0.003	CcSEcCtD
Flunisolide—Anxiety—Pravastatin—atherosclerosis	0.00138	0.00299	CcSEcCtD
Flunisolide—Dyspnoea—Ezetimibe—atherosclerosis	0.00137	0.00298	CcSEcCtD
Flunisolide—Discomfort—Pravastatin—atherosclerosis	0.00137	0.00297	CcSEcCtD
Flunisolide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00136	0.00296	CcSEcCtD
Flunisolide—Decreased appetite—Lovastatin—atherosclerosis	0.00136	0.00296	CcSEcCtD
Flunisolide—Dyspepsia—Ezetimibe—atherosclerosis	0.00135	0.00294	CcSEcCtD
Flunisolide—Fatigue—Lovastatin—atherosclerosis	0.00135	0.00294	CcSEcCtD
Flunisolide—Oedema—Niacin—atherosclerosis	0.00135	0.00293	CcSEcCtD
Flunisolide—Constipation—Lovastatin—atherosclerosis	0.00134	0.00291	CcSEcCtD
Flunisolide—Pain—Lovastatin—atherosclerosis	0.00134	0.00291	CcSEcCtD
Flunisolide—Decreased appetite—Ezetimibe—atherosclerosis	0.00134	0.0029	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00134	0.0029	CcSEcCtD
Flunisolide—Asthenia—Rosuvastatin—atherosclerosis	0.00133	0.00288	CcSEcCtD
Flunisolide—Insomnia—Simvastatin—atherosclerosis	0.00133	0.00288	CcSEcCtD
Flunisolide—Oedema—Pravastatin—atherosclerosis	0.00133	0.00288	CcSEcCtD
Flunisolide—Fatigue—Ezetimibe—atherosclerosis	0.00133	0.00288	CcSEcCtD
Flunisolide—Shock—Niacin—atherosclerosis	0.00132	0.00288	CcSEcCtD
Flunisolide—Infection—Pravastatin—atherosclerosis	0.00132	0.00286	CcSEcCtD
Flunisolide—Pain—Ezetimibe—atherosclerosis	0.00131	0.00286	CcSEcCtD
Flunisolide—Constipation—Ezetimibe—atherosclerosis	0.00131	0.00286	CcSEcCtD
Flunisolide—Tachycardia—Niacin—atherosclerosis	0.00131	0.00286	CcSEcCtD
Flunisolide—Pruritus—Rosuvastatin—atherosclerosis	0.00131	0.00284	CcSEcCtD
Flunisolide—Dyspnoea—Simvastatin—atherosclerosis	0.00131	0.00284	CcSEcCtD
Flunisolide—Hyperhidrosis—Niacin—atherosclerosis	0.0013	0.00283	CcSEcCtD
Flunisolide—Feeling abnormal—Lovastatin—atherosclerosis	0.00129	0.00281	CcSEcCtD
Flunisolide—Dyspepsia—Simvastatin—atherosclerosis	0.00129	0.0028	CcSEcCtD
Flunisolide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00128	0.00279	CcSEcCtD
Flunisolide—Hyperhidrosis—Pravastatin—atherosclerosis	0.00128	0.00278	CcSEcCtD
Flunisolide—Decreased appetite—Simvastatin—atherosclerosis	0.00127	0.00277	CcSEcCtD
Flunisolide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00127	0.00275	CcSEcCtD
Flunisolide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00127	0.00275	CcSEcCtD
Flunisolide—Fatigue—Simvastatin—atherosclerosis	0.00126	0.00275	CcSEcCtD
Flunisolide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00126	0.00273	CcSEcCtD
Flunisolide—Constipation—Simvastatin—atherosclerosis	0.00125	0.00272	CcSEcCtD
Flunisolide—Pain—Simvastatin—atherosclerosis	0.00125	0.00272	CcSEcCtD
Flunisolide—Urticaria—Lovastatin—atherosclerosis	0.00125	0.00271	CcSEcCtD
Flunisolide—Body temperature increased—Lovastatin—atherosclerosis	0.00124	0.00269	CcSEcCtD
Flunisolide—Abdominal pain—Lovastatin—atherosclerosis	0.00124	0.00269	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00123	0.00267	CcSEcCtD
Flunisolide—Dizziness—Rosuvastatin—atherosclerosis	0.00122	0.00266	CcSEcCtD
Flunisolide—Urticaria—Ezetimibe—atherosclerosis	0.00122	0.00265	CcSEcCtD
Flunisolide—Insomnia—Niacin—atherosclerosis	0.00122	0.00265	CcSEcCtD
Flunisolide—Abdominal pain—Ezetimibe—atherosclerosis	0.00122	0.00264	CcSEcCtD
Flunisolide—Body temperature increased—Ezetimibe—atherosclerosis	0.00122	0.00264	CcSEcCtD
Flunisolide—Feeling abnormal—Simvastatin—atherosclerosis	0.00121	0.00263	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00121	0.00262	CcSEcCtD
Flunisolide—Dyspnoea—Niacin—atherosclerosis	0.0012	0.00261	CcSEcCtD
Flunisolide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0012	0.00261	CcSEcCtD
Flunisolide—Insomnia—Pravastatin—atherosclerosis	0.0012	0.00261	CcSEcCtD
Flunisolide—Dyspepsia—Niacin—atherosclerosis	0.00118	0.00258	CcSEcCtD
Flunisolide—Dyspnoea—Pravastatin—atherosclerosis	0.00118	0.00257	CcSEcCtD
Flunisolide—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.00118	0.0315	CbGpPWpGaD
Flunisolide—Decreased appetite—Niacin—atherosclerosis	0.00117	0.00254	CcSEcCtD
Flunisolide—Dyspepsia—Pravastatin—atherosclerosis	0.00117	0.00254	CcSEcCtD
Flunisolide—Rash—Rosuvastatin—atherosclerosis	0.00117	0.00253	CcSEcCtD
Flunisolide—Dermatitis—Rosuvastatin—atherosclerosis	0.00117	0.00253	CcSEcCtD
Flunisolide—Urticaria—Simvastatin—atherosclerosis	0.00116	0.00253	CcSEcCtD
Flunisolide—Abdominal pain—Simvastatin—atherosclerosis	0.00116	0.00252	CcSEcCtD
Flunisolide—Body temperature increased—Simvastatin—atherosclerosis	0.00116	0.00252	CcSEcCtD
Flunisolide—Headache—Rosuvastatin—atherosclerosis	0.00116	0.00252	CcSEcCtD
Flunisolide—Hypersensitivity—Lovastatin—atherosclerosis	0.00115	0.00251	CcSEcCtD
Flunisolide—Decreased appetite—Pravastatin—atherosclerosis	0.00115	0.0025	CcSEcCtD
Flunisolide—Pain—Niacin—atherosclerosis	0.00115	0.0025	CcSEcCtD
Flunisolide—Fatigue—Pravastatin—atherosclerosis	0.00114	0.00248	CcSEcCtD
Flunisolide—Pain—Pravastatin—atherosclerosis	0.00113	0.00246	CcSEcCtD
Flunisolide—Constipation—Pravastatin—atherosclerosis	0.00113	0.00246	CcSEcCtD
Flunisolide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00113	0.00246	CcSEcCtD
Flunisolide—Asthenia—Lovastatin—atherosclerosis	0.00112	0.00244	CcSEcCtD
Flunisolide—Pruritus—Lovastatin—atherosclerosis	0.00111	0.00241	CcSEcCtD
Flunisolide—Asthenia—Ezetimibe—atherosclerosis	0.0011	0.0024	CcSEcCtD
Flunisolide—Gastrointestinal pain—Niacin—atherosclerosis	0.0011	0.00239	CcSEcCtD
Flunisolide—Nausea—Rosuvastatin—atherosclerosis	0.0011	0.00239	CcSEcCtD
Flunisolide—Feeling abnormal—Pravastatin—atherosclerosis	0.00109	0.00237	CcSEcCtD
Flunisolide—Pruritus—Ezetimibe—atherosclerosis	0.00109	0.00236	CcSEcCtD
Flunisolide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00108	0.00236	CcSEcCtD
Flunisolide—Hypersensitivity—Simvastatin—atherosclerosis	0.00108	0.00235	CcSEcCtD
Flunisolide—Diarrhoea—Lovastatin—atherosclerosis	0.00107	0.00233	CcSEcCtD
Flunisolide—Urticaria—Niacin—atherosclerosis	0.00107	0.00232	CcSEcCtD
Flunisolide—Body temperature increased—Niacin—atherosclerosis	0.00106	0.00231	CcSEcCtD
Flunisolide—Abdominal pain—Niacin—atherosclerosis	0.00106	0.00231	CcSEcCtD
Flunisolide—Urticaria—Pravastatin—atherosclerosis	0.00105	0.00229	CcSEcCtD
Flunisolide—Asthenia—Simvastatin—atherosclerosis	0.00105	0.00229	CcSEcCtD
Flunisolide—Diarrhoea—Ezetimibe—atherosclerosis	0.00105	0.00229	CcSEcCtD
Flunisolide—Body temperature increased—Pravastatin—atherosclerosis	0.00105	0.00228	CcSEcCtD
Flunisolide—Abdominal pain—Pravastatin—atherosclerosis	0.00105	0.00228	CcSEcCtD
Flunisolide—Pruritus—Simvastatin—atherosclerosis	0.00104	0.00225	CcSEcCtD
Flunisolide—Dizziness—Lovastatin—atherosclerosis	0.00104	0.00225	CcSEcCtD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.00103	0.0277	CbGpPWpGaD
Flunisolide—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.00102	0.0272	CbGpPWpGaD
Flunisolide—Dizziness—Ezetimibe—atherosclerosis	0.00102	0.00221	CcSEcCtD
Flunisolide—Diarrhoea—Simvastatin—atherosclerosis	0.001	0.00218	CcSEcCtD
Flunisolide—Vomiting—Lovastatin—atherosclerosis	0.000997	0.00217	CcSEcCtD
Flunisolide—Hypersensitivity—Niacin—atherosclerosis	0.000992	0.00216	CcSEcCtD
Flunisolide—Rash—Lovastatin—atherosclerosis	0.000988	0.00215	CcSEcCtD
Flunisolide—Dermatitis—Lovastatin—atherosclerosis	0.000987	0.00215	CcSEcCtD
Flunisolide—Headache—Lovastatin—atherosclerosis	0.000982	0.00213	CcSEcCtD
Flunisolide—Vomiting—Ezetimibe—atherosclerosis	0.000977	0.00212	CcSEcCtD
Flunisolide—Hypersensitivity—Pravastatin—atherosclerosis	0.000976	0.00212	CcSEcCtD
Flunisolide—Dizziness—Simvastatin—atherosclerosis	0.000969	0.00211	CcSEcCtD
Flunisolide—Rash—Ezetimibe—atherosclerosis	0.000969	0.00211	CcSEcCtD
Flunisolide—Dermatitis—Ezetimibe—atherosclerosis	0.000968	0.0021	CcSEcCtD
Flunisolide—Asthenia—Niacin—atherosclerosis	0.000966	0.0021	CcSEcCtD
Flunisolide—Headache—Ezetimibe—atherosclerosis	0.000963	0.00209	CcSEcCtD
Flunisolide—Pruritus—Niacin—atherosclerosis	0.000952	0.00207	CcSEcCtD
Flunisolide—Asthenia—Pravastatin—atherosclerosis	0.000951	0.00207	CcSEcCtD
Flunisolide—Pruritus—Pravastatin—atherosclerosis	0.000938	0.00204	CcSEcCtD
Flunisolide—Vomiting—Simvastatin—atherosclerosis	0.000932	0.00203	CcSEcCtD
Flunisolide—Nausea—Lovastatin—atherosclerosis	0.000931	0.00202	CcSEcCtD
Flunisolide—Rash—Simvastatin—atherosclerosis	0.000924	0.00201	CcSEcCtD
Flunisolide—Dermatitis—Simvastatin—atherosclerosis	0.000923	0.00201	CcSEcCtD
Flunisolide—Diarrhoea—Niacin—atherosclerosis	0.000921	0.002	CcSEcCtD
Flunisolide—Headache—Simvastatin—atherosclerosis	0.000918	0.002	CcSEcCtD
Flunisolide—Nausea—Ezetimibe—atherosclerosis	0.000913	0.00198	CcSEcCtD
Flunisolide—Diarrhoea—Pravastatin—atherosclerosis	0.000907	0.00197	CcSEcCtD
Flunisolide—Dizziness—Niacin—atherosclerosis	0.00089	0.00193	CcSEcCtD
Flunisolide—Dizziness—Pravastatin—atherosclerosis	0.000876	0.0019	CcSEcCtD
Flunisolide—Nausea—Simvastatin—atherosclerosis	0.000871	0.00189	CcSEcCtD
Flunisolide—Vomiting—Niacin—atherosclerosis	0.000856	0.00186	CcSEcCtD
Flunisolide—Rash—Niacin—atherosclerosis	0.000849	0.00184	CcSEcCtD
Flunisolide—Dermatitis—Niacin—atherosclerosis	0.000848	0.00184	CcSEcCtD
Flunisolide—Dexamethasone—NOS2—atherosclerosis	0.000844	0.112	CrCbGaD
Flunisolide—Headache—Niacin—atherosclerosis	0.000843	0.00183	CcSEcCtD
Flunisolide—Vomiting—Pravastatin—atherosclerosis	0.000843	0.00183	CcSEcCtD
Flunisolide—Rash—Pravastatin—atherosclerosis	0.000836	0.00182	CcSEcCtD
Flunisolide—Dermatitis—Pravastatin—atherosclerosis	0.000835	0.00181	CcSEcCtD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.000834	0.0223	CbGpPWpGaD
Flunisolide—Headache—Pravastatin—atherosclerosis	0.00083	0.0018	CcSEcCtD
Flunisolide—Nausea—Niacin—atherosclerosis	0.0008	0.00174	CcSEcCtD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.00079	0.0211	CbGpPWpGaD
Flunisolide—Nausea—Pravastatin—atherosclerosis	0.000787	0.00171	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.000777	0.0208	CbGpPWpGaD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000769	0.0206	CbGpPWpGaD
Flunisolide—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.000704	0.0188	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.000653	0.0175	CbGpPWpGaD
Flunisolide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000646	0.0173	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.000642	0.0172	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—RETN—atherosclerosis	0.000637	0.017	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.000607	0.0162	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—F7—atherosclerosis	0.000576	0.0154	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.000559	0.015	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.000516	0.0138	CbGpPWpGaD
Flunisolide—Triamcinolone—PTGS2—atherosclerosis	0.000509	0.0673	CrCbGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.000492	0.0132	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000487	0.013	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.000447	0.0119	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000442	0.0118	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.000437	0.0117	CbGpPWpGaD
Flunisolide—Betamethasone—PTGS2—atherosclerosis	0.000417	0.0551	CrCbGaD
Flunisolide—Prednisone—ALB—atherosclerosis	0.000411	0.0543	CrCbGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.000403	0.0108	CbGpPWpGaD
Flunisolide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.000396	0.0106	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.000396	0.0106	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000382	0.0102	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.000375	0.01	CbGpPWpGaD
Flunisolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.000369	0.00986	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000365	0.00975	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.000361	0.00966	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—AHR—atherosclerosis	0.000349	0.00933	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000348	0.0093	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.000345	0.00924	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.000333	0.00889	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.000325	0.0087	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000315	0.00843	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.000313	0.00837	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000313	0.00837	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00031	0.00829	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000309	0.00827	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000305	0.00816	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000303	0.00811	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.000297	0.00795	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000289	0.00773	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000286	0.00764	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00028	0.0075	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000277	0.0074	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000275	0.00736	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000263	0.00703	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.00026	0.00694	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000259	0.00693	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000256	0.00684	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.00025	0.00668	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.000243	0.0065	CbGpPWpGaD
Flunisolide—Dexamethasone—PTGS2—atherosclerosis	0.000242	0.032	CrCbGaD
Flunisolide—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000242	0.00648	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.00024	0.00641	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.000232	0.0062	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000228	0.0061	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000227	0.00608	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000216	0.00578	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000214	0.00572	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000211	0.00564	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.000211	0.00563	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00021	0.00562	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.000208	0.00555	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000186	0.00497	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000185	0.00495	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000182	0.00486	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000178	0.00475	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000169	0.00452	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000163	0.00437	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000163	0.00436	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.00016	0.00429	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000158	0.00423	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000158	0.00423	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000155	0.00415	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000153	0.00409	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000149	0.00398	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000135	0.00361	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000133	0.00357	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—INS—atherosclerosis	0.000132	0.00354	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000131	0.0035	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000131	0.0035	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000129	0.00345	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000128	0.00343	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000127	0.0034	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000126	0.00337	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000122	0.00325	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000121	0.00323	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000119	0.00319	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000114	0.00306	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000112	0.00299	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00011	0.00294	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	9.5e-05	0.00254	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	9.41e-05	0.00252	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	8.91e-05	0.00238	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	8.91e-05	0.00238	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	8.54e-05	0.00228	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	8.37e-05	0.00224	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—STAT3—atherosclerosis	8.29e-05	0.00222	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	7.97e-05	0.00213	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	7.8e-05	0.00209	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	7.72e-05	0.00206	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TGFB1—atherosclerosis	7.68e-05	0.00205	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	7.23e-05	0.00193	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TNF—atherosclerosis	7.17e-05	0.00192	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	6.2e-05	0.00166	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	5.97e-05	0.0016	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—atherosclerosis	5.79e-05	0.00155	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	5.41e-05	0.00145	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HSPA1B—atherosclerosis	5.08e-05	0.00136	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	5e-05	0.00134	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.99e-05	0.00133	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	4.93e-05	0.00132	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.92e-05	0.00132	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PARP1—atherosclerosis	4.53e-05	0.00121	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.44e-05	0.00119	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR2—atherosclerosis	4.29e-05	0.00115	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.54e-05	0.000946	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SIRT1—atherosclerosis	3.46e-05	0.000924	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PLTP—atherosclerosis	3.32e-05	0.000889	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.88e-05	0.000771	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.88e-05	0.000771	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPARA—atherosclerosis	2.87e-05	0.000768	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR1—atherosclerosis	2.6e-05	0.000696	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPARG—atherosclerosis	2.37e-05	0.000635	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.28e-05	0.000609	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—FABP4—atherosclerosis	2.14e-05	0.000573	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LCAT—atherosclerosis	2.14e-05	0.000573	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SERPINE1—atherosclerosis	2.14e-05	0.000572	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOA4—atherosclerosis	2.1e-05	0.000562	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.07e-05	0.000552	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.91e-05	0.000511	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.81e-05	0.000484	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.81e-05	0.000484	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOA2—atherosclerosis	1.81e-05	0.000484	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.81e-05	0.000484	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.79e-05	0.000478	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LPA—atherosclerosis	1.73e-05	0.000462	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—BGN—atherosclerosis	1.67e-05	0.000447	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOA5—atherosclerosis	1.66e-05	0.000443	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.59e-05	0.000426	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.54e-05	0.000412	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MAPK3—atherosclerosis	1.39e-05	0.000372	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.38e-05	0.000369	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LIPC—atherosclerosis	1.37e-05	0.000367	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOC3—atherosclerosis	1.36e-05	0.000365	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.35e-05	0.000362	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CETP—atherosclerosis	1.32e-05	0.000354	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.27e-05	0.000339	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.2e-05	0.00032	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.07e-05	0.000285	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AKT1—atherosclerosis	9.39e-06	0.000251	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.15e-06	0.000245	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOB—atherosclerosis	8.77e-06	0.000234	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.53e-06	0.000228	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—LPL—atherosclerosis	8.37e-06	0.000224	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPX1—atherosclerosis	8.17e-06	0.000218	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CD36—atherosclerosis	7.95e-06	0.000213	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.54e-06	0.000202	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARA—atherosclerosis	7.39e-06	0.000198	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AGT—atherosclerosis	7.16e-06	0.000192	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOE—atherosclerosis	7.02e-06	0.000188	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CAV1—atherosclerosis	6.95e-06	0.000186	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOA1—atherosclerosis	6.94e-06	0.000185	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.33e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARG—atherosclerosis	6.11e-06	0.000163	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—INS—atherosclerosis	5.99e-06	0.00016	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALB—atherosclerosis	5.5e-06	0.000147	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NOS3—atherosclerosis	5.26e-06	0.000141	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.81e-06	0.000129	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKT1—atherosclerosis	2.42e-06	6.46e-05	CbGpPWpGaD
